The store will not work correctly when cookies are disabled.
2-(2-phenylthiochroman-4-ylidene)hydrazinecarboxamide
ID: ALA4568780
PubChem CID: 155560274
Max Phase: Preclinical
Molecular Formula: C16H15N3OS
Molecular Weight: 297.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)N/N=C1\CC(c2ccccc2)Sc2ccccc21
Standard InChI: InChI=1S/C16H15N3OS/c17-16(20)19-18-13-10-15(11-6-2-1-3-7-11)21-14-9-5-4-8-12(13)14/h1-9,15H,10H2,(H3,17,19,20)/b18-13+
Standard InChI Key: ITTGCIUJJOATTI-QGOAFFKASA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
4.3085 -4.6596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3073 -5.4866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0217 -5.8991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0199 -4.2472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7349 -4.6560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7337 -5.4840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4462 -5.8967 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.1644 -5.4861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1657 -4.6580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4485 -4.2407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8772 -5.8964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8735 -6.7220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5856 -7.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3017 -6.7259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3014 -5.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5888 -5.4867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4486 -3.4162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1626 -3.0040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1626 -2.1795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8767 -1.7673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4486 -1.7673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
8 11 1 0
10 17 2 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 297.38 | Molecular Weight (Monoisotopic): 297.0936 | AlogP: 3.30 | #Rotatable Bonds: 2 |
Polar Surface Area: 67.48 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.81 | CX Basic pKa: 1.13 | CX LogP: 2.76 | CX LogD: 2.76 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.84 | Np Likeness Score: -0.82 |
References
1. Scarim CB, Jornada DH, Machado MGM, Ferreira CMR, Dos Santos JL, Chung MC.. (2019) Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria., 162 [PMID:30453246] [10.1016/j.ejmech.2018.11.013] |